(Q80720176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

end-stage liver disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Herschel A Carpenter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Albert J Czaja

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1138-1145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

Treatment strategies in autoimmune hepatitis

2 January 2020

cites work

1 reference

7 January 2021

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial

1 reference

7 January 2021

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

1 reference

7 January 2021

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

1 reference

7 January 2021

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

1 reference

7 January 2021

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

1 reference

7 January 2021

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

1 reference

7 January 2021

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

1 reference

7 January 2021

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

1 reference

7 January 2021

Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate

1 reference

7 January 2021

Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature

1 reference

7 January 2021

Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis

1 reference

7 January 2021

Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy

1 reference

7 January 2021

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

7 January 2021

Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report

1 reference

7 January 2021

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

1 reference

7 January 2021

Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis

1 reference

7 January 2021

Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis

1 reference

7 January 2021

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases

1 reference

7 January 2021

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

1 reference

7 January 2021

The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients

1 reference

7 January 2021

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

1 reference

7 January 2021

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

7 January 2021

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

1 reference

7 January 2021

A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis

1 reference

7 January 2021

Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease

1 reference

7 January 2021

The model for end-stage liver disease (MELD)

1 reference

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

7 January 2021

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

7 January 2021

MELD accurately predicts mortality in patients with alcoholic hepatitis

1 reference

7 January 2021

MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation

1 reference

7 January 2021

MELD score as a prognostic model for listing acute liver failure patients for liver transplantation

1 reference

7 January 2021

Renal Failure in Patients With Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD Score

1 reference

7 January 2021

Adrenal failure in liver transplant patients: does steroid-free immunosuppression place recipients at risk for an adrenal crisis?

1 reference

7 January 2021

Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system

1 reference

7 January 2021

Diagnosis and treatment of autoimmune hepatitis

1 reference

7 January 2021

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

7 January 2021

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

7 January 2021

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

1 reference

7 January 2021

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

7 January 2021

Chronic hepatitis. An update on terminology and reporting.

1 reference

7 January 2021

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

7 January 2021

Effects of meals and interruption of enterohepatic circulation on flow, lipid composition, and cholesterol saturation of bile in man after cholecystectomy

1 reference

7 January 2021

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

7 January 2021

Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

7 January 2021

Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis

1 reference

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

7 January 2021

Severe chronic active liver disease. Prognostic significance of initial morphologic patterns

1 reference

7 January 2021

Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis

1 reference

7 January 2021

Treatment challenges and investigational opportunities in autoimmune hepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17668882%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference